In vitro drug susceptibility of 2275 clinical non-tuberculous Mycobacterium isolates of 49 species in The Netherlands
- 16 December 2009
- journal article
- research article
- Published by Elsevier
- Vol. 35 (2) , 169-173
- https://doi.org/10.1016/j.ijantimicag.2009.09.023
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- A Novel Gene,erm(41), Confers Inducible Macrolide Resistance to Clinical Isolates ofMycobacterium abscessusbut Is Absent fromMycobacterium chelonaeAntimicrobial Agents and Chemotherapy, 2009
- Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, The NetherlandsThorax, 2009
- Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapyThorax, 2008
- Clinical relevance ofMycobacterium simiaein pulmonary samplesEuropean Respiratory Journal, 2007
- In Vitro and In Vivo Activities of Novel Fluoroquinolones Alone and in Combination with Clarithromycin against Clinically Isolated Mycobacterium avium Complex Strains in JapanAntimicrobial Agents and Chemotherapy, 2007
- Drug Susceptibility Testing of Mycobacterium tuberculosis Complex by Use of a High-Throughput, Reproducible, Absolute Concentration MethodJournal of Clinical Microbiology, 2007
- A multigene approach to phylogenetic analysis using the genus Mycobacterium as a modelInternational Journal of Systematic and Evolutionary Microbiology, 2005
- Efflux Pump-Mediated Intrinsic Drug Resistance in Mycobacterium smegmatisAntimicrobial Agents and Chemotherapy, 2004
- Rifampin Resistance in Mycobacterium kansasii Is Associated with rpoB MutationsAntimicrobial Agents and Chemotherapy, 2001
- First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutolThorax, 2001